Citigroup Adjusts Price Target on Globant to $46 From $37, Maintains Neutral Rating

Citigroup raised its price target for Globant to $46 from $37, maintaining a neutral rating. Globant's stock has seen a 5-day change of -1.64%, a 1st Jan change of +13.83%, and a -31.12% change over a longer period. The adjustments are based on various composite ratings including valuation, EPS revisions, and visibility.

Original reporting
Published Oct 26, 2026, 11:18 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 11:55 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$GLOB
Bullish
high confidence
Mentioned
$GLOB
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$GLOBBullishMed
01

Why it matters

The target increase may attract short‑term buyers, but the neutral rating tempers expectations of a strong rally.

02

Market read

Analyst target revisions are a common catalyst for mid‑cap tech stocks, offering a modest trading edge.

03

What to watch

Potential macro headwinds in emerging markets could dampen Globant's growth despite the higher target.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

Citigroup's research note updates its valuation model for Globant, reflecting recent client wins and market trends.

Company-level read

Ticker impact

$GLOBBullishHigh confidence
Context

Citigroup raised Globant's price target to $46 from $37 and kept a neutral rating.

Expected impact

upward pressure as investors price in higher valuation expectations

Evidence & confidence

Analyst target hikes are a direct catalyst that can prompt buying, especially when the target jump is ~24%.

Market effects

Software & IT services sector may see modest uplift from the upgraded target.

Latin America exposure could benefit as Globant is a key player in the region.

Limited to investors tracking analyst coverage of mid‑cap tech stocks.

Counterpoint

The neutral rating suggests limited upside; the target raise may be premature if earnings miss expectations.

Key entities

  • Citigroup

    Provides equity research and price target updates.

  • Globant

    Argentina‑based digital transformation firm listed on NASDAQ.

Related articles

$GLOBHigh

Why Globant Stock Wilted by 5% on Wednesday

Globant (GLOB) stock fell 5% after Guggenheim analyst Jonathan Lee downgraded it to neutral, citing fading upside potential and softness in Middle East business. Lee removed his $50 price target, but praised the company's AI efforts. The downgrade came ahead of Globant's Q3 earnings report.

$GLOBMed

Guggenheim downgrades Globant stock rating citing soft bookings

Guggenheim downgraded Globant (NYSE:GLOB) to Neutral, citing soft bookings, Middle East weakness, and flat growth. The firm removed its $50 price target, noting concerns about a large gaming client and a potential sequential decline in Q1 2027. Shares trade at a P/E of 18.74 and a market cap of $2.11B. Other analysts have mixed views, with targets ranging from $37 to $45.

$GLOBMedAI 8/10

Why is Globant stock surging today?

Globant (GLOB) stock rose 7.5% to $37.30, driven by investor confidence in its AI strategy and partnerships, including deals with Anthropic and Salesforce. The company's share buyback program and Q2 2026 EPS beat also contributed. GLOB's valuation remains below analyst targets, and the broader market had a neutral impact.

$GLOBHighAI 8/10

Globant’s (GLOB) AI Pivot Masks A Slowing Legacy Business

Globant (GLOB) reported Q2 2026 earnings, highlighting 61% growth in AI Pod revenue to $52.8M and a $436.8M pipeline. However, core revenue grew just 1.2% sequentially, and guidance was cut. Margins slipped, and the company reduced its workforce. Hedge fund holdings declined, and short interest is high at 18.31% of float. The stock trades at a forward P/E of 6.49, reflecting low earnings growth expectations.